A carregar...

Twin pregnancy outcome following teriflunomide treatment in a relapsing-remitting multiple sclerosis patient: A case report

RATIONALE: Teriflunomide is a disease-modifying drug that has been approved for treatment of relapsing-remitting multiple sclerosis. Due to its teratogenic effect in animals, however, it is not recommended during pregnancy. For this reason, effective contraception must be used during its administrat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: D’Aleo, Giangaetano, Rifici, Carmela, Donato, Antonina, Corallo, Francesco, Di Cara, Marcella, Bramanti, Placido, Sessa, Edoardo
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7360296/
https://ncbi.nlm.nih.gov/pubmed/32664171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000021212
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!